Improving the trans-ancestry portability of polygenic risk scores by prioritizing variants in predicted cell-type-specific regulatory elements.
- Authors
- Amariuta, Tiffany; Ishigaki, Kazuyoshi; Sugishita, Hiroki; Ohta, Tazro; Koido, Masaru; Dey, Kushal K; Matsuda, Koichi; Murakami, Yoshinori; Price, Alkes L; Kawakami, Eiryo; Terao, Chikashi; Raychaudhuri, Soumya
- Year
- 2020
- Journal
- Nature genetics
- PMID
- 33257898
- DOI
- 10.1038/s41588-020-00740-8
- PMCID
- PMC8049522
Poor trans-ancestry portability of polygenic risk scores is a consequence of Eurocentric genetic studies and limited knowledge of shared causal variants. Leveraging regulatory annotations may improve portability by prioritizing functional over tagging variants. We constructed a resource of 707 cell-type-specific IMPACT regulatory annotations by aggregating 5,345 epigenetic datasets to predict binding patterns of 142 transcription factors across 245 cell types. We then partitioned the common SNP heritability of 111 genome-wide association study summary statistics of European (average nβββ189,000) and East Asian (average nβββ157,000) origin. IMPACT annotations captured consistent SNP heritability between populations, suggesting prioritization of shared functional variants. Variant prioritization using IMPACT resulted in increased trans-ancestry portability of polygenic risk scores from Europeans to East Asians across all 21 phenotypes analyzed (49.9% mean relative increase in R). Our study identifies a crucial role for functional annotations such as IMPACT to improve the trans-ancestry portability of genetic data.
Study design to identify regulatory annotations that prioritize regulatory variants in a multi-ancestry setting.a, Population-specific LD confounding and subsequent inflation of GWAS associations complicate the interpretation of summary statistics and transferability to other populations; functional data may help improve trans-ancestry genetic portability. b, Prism of functional data in IMPACT model: 707 genome-wide TF occupancy profiles (green), 5,345 genome-wide epigenomic feature profiles (blue), and fitted weights for these features (pink) to predict TF binding by logistic regression. Using IMPACT annotations, we investigate 111 GWAS summary datasets (yellow) of EUR and EAS origin. p, probability of site-specific TF binding. c, Compendium of 707 genome-wide cell-type-specific IMPACT regulatory annotations. d, Annotations that prioritize common regulatory variants must capture large proportions of heritability in both populations (i), account for consistent marginal effect size estimations between populations (ii) and improve the trans-ancestry application of PRS (iii). h2 denotes the trait heritability, or genetic variation, causally explained by common SNPs. In (ii), the x and y axes show the the marginal effect sizes observed in EUR and EAS GWAS, respectively.
Common per-SNP heritability (Ο*) estimate for sets of independent IMPACT cell type annotations across 29 traits.Dotted line is the identity line, y=x. Ο* values with their standard errors are colored green if significantly positive in EUR and not EAS, red if significantly positive in EAS but not in EUR, green if significantly positive in both EUR and EAS, and gray if not significantly positive in either population.
Population concordance of heterozygosity (2pq) among variants prioritized by IMPACT compared to standard P+T.a) Heterozygosity of variants from genome-wide EUR and EAS PrCa summary statistics in the top 5% of the lead IMPACT annotation for EUR PrCa. b) Heterozygosity of variants from genome-wide EUR and EAS PrCa summary statistics using standard P+T. c) Heterozygosity of variants from genome-wide EUR and EAS PrCa summary statistics in the bottom 95% of the lead IMPACT annotation for PrCa; mutually exclusive with SNPs in A). d) Meta-analysis of heterozygosity correlations between populations across 21 traits shared between EUR and EAS cohorts over 17 GWAS P value thresholds (with reference to the EUR GWAS).
Population divergence, measured by Fst, among variants prioritized by IMPACT compared to standard P+T.Larger values indicate a reduction in heterozygosity. Meta-analysis of Fst between EUR and EAS populations across 21 traits shared between EUR and EAS cohorts over 17 GWAS P value thresholds (with reference to the EUR GWAS).
EuR PRS model evaluated on EAS individuals from BBJ.For each trait, we evaluate the predictive value of standard PRS models (top 100% of IMPACT SNPs) and functionally informed PRS models (using a subset of SNPs prioritized by IMPACT). The top 100% of SNPs according to IMPACT represents the PRS model with no functional annotation information. Intervals represent the 95% CI around the R2 estimate. For quantitative traits, R2 represents the proportion of variance captured by the linear PRS model. For caseβcontrol traits, R2 represents the liability scale R2 from the logistic regression PRS model.
Trans-ethnic and within-population PRS models evaluated on the same 5,000 BBJ individuals.a) Phenotypic variance (R2) in 5,000 BBJ individuals explained by IMPACT-informed PRS-EUR (light pink) and standard PRS-EUR (light blue). b) Phenotypic variance (R2) in 5,000 BBJ individuals explained by IMPACT-informed PRS-EAS (light pink) and standard PRS-EAS (light blue). Error bars indicate 95% CI calculated via 1,000 bootstraps.
PRS accuracy is robust to loci of large effect.We recomputed confidence intervals around the R2 estimates (panels A and B) and around the relative improvements in R2 estimates of IMPACT PRS over standard P+T PRS (panels C and D) via block jackknife across the genome, using 200 adjacent equally-sized bins and iteratively removing variants within each bin and computing the R2. a) Trans-ethnic analysis of EUR PRS to BBJ individuals. b) Within-population analysis of EAS PRS to BBJ individuals. Error bars indicate 95% confidence interval (CI) around the R2 estimates. c) Trans-ethnic analysis of EUR PRS to BBJ individuals, relative improvement in R2 estimates defined as (IMPACT R2 - standard P+T R2)/standard P+T R2. d) Within-population analysis of EAS PRS to BBJ individuals, relative improvement in R2 estimates defined as (IMPACT R2 - standard P+T R2)/standard P+T R2.
IMPACT annotates relevant cell-type-specific regulatory elements.a, Low-dimensional embedding and clustering of 707 IMPACT annotations using uniform manifold approximation projection (UMAP). Annotations colored by cell-type category; TF groups indicated where applicable. b, Biologically distinct regulatory modules revealed by cell typeβtrait associations with significantly nonzero Ο*. Shown here are the 5 representative EUR complex traits and the 4 leading IMPACT annotations for each, resulting in 20 IMPACT annotations highlighted from 707 in total. Color indicates Ο* value. c, Lead IMPACT annotations capture more heritability than lead cell-type-specific histone modifications across 60 of 69 EUR summary statistics for which a lead IMPACT annotation was identified. The asterisk indicates the proportion-of-heritability-estimate difference of means P < 0.05. Gray segments indicate the 95% CI around the proportion-of-heritability estimate.
Trans-ancestry concordance of regulatory elements defined by IMPACT.a, Illustrative concept of concordance versus discordance of Ο* between populations. Concordance implies a similar distribution of causal variants and effects captured by the same annotation. The implications of discordant Ο* are not as straightforward. b, Common per-SNP heritability (Ο*) estimate for sets of independent IMPACT annotations across 29 traits shared between EUR and EAS. Left: color indicates Ο* significance (sig.; Ο* greater than 0 at 5% FDR). Line of best fit through annotations significant in both populations (dark purple line, 95% CI in light purple). Black dotted line is the identity line, y = x. Right: color indicates association to one of five exemplary traits.
Mechanism by which IMPACT prioritization of shared regulatory variants might improve trans-ancestry PRS performance.a, Estimated effect sizes of variants from genome-wide EUR and EAS height summary statistics in the top 5% of the lead IMPACT annotation for EUR height. Proportions of variants in each quadrant indicated in light blue. b, Estimated effect sizes from genome-wide EUR and EAS height summary statistics of variants in the bottom 95% of the same lead IMPACT annotation for height; mutually exclusive with SNPs in a. c, Meta-analysis of trans-ancestry marginal effect size correlations between populations across 21 traits shared between EUR and EAS cohorts over 17 GWAS P value thresholds (with reference to the EUR GWAS). Vertical bars indicate the 95% CI around the Pearson r estimate. d, Number of SNPs (log10 scale) at each P value threshold for each partition of the genome corresponding to c. Error bars indicate 1 s.d. above and below the mean.
Identifying shared regulatory variants with IMPACT annotations to improve the trans-ancestry portability of PRS.a, Study design applying EUR summary statistics-based PRS models to all individuals in the BBJ cohort. b, Phenotypic variance (R2) of BBJ individuals explained by EUR PRS using two methods: functionally informed PRS with IMPACT (pink) and standard PRS (blue). Error bars indicate 95% CI calculated via 1,000 bootstraps. c, Phenotypic variance (R2) of BBJ individuals across five exemplary traits explained by EUR IMPACT annotations relative to lead deep learning annotations (DL), cell-type-specific histone modification annotations (CTS) and lead cell-type-specifically expressed gene sets (SEG). Error bars indicate 95% CI calculated via 1,000 bootstraps. d, Study design to compare trans-ancestry (EUR to EAS) to within-population (EAS to EAS) improvement afforded by functionally informed PRS models. For each trait, 5,000 randomly selected individuals from BBJ were designated as PRS samples. The remaining BBJ individuals were used for GWAS to derive EAS summary statisticsβbased PRS; no shared individuals between GWAS samples and PRS samples. e, Improvement from standard PRS to functionally informed PRS compared between trans-ancestry (EUR to EAS) and within-population models (EAS to EAS) using the study design in d. In the boxplots, the center line indicates the median value; box limits indicate the upper (third) and lower (first) quartiles; the lengths of the whiskers indicate values up to 1.5 times the IQR in either direction.
Data collection.a) TF ChIP-seq collection from NCBI: (left) cell type and TF diversity where βCell Derivβ indicates number of unique parental cell types, for example GM12878 and GM10847 are both B cell lines, (right) diversity of tissue types. b) (left) Epigenomic and sequence features to be used in IMPACT models, (right) diversity of histone modification ChIP-seq in features. c) Diversity of European (EUR) and East Asian (EAS) GWAS summary statistics across phenotypic categories.
IMPACT annotation-trait associations.Significant cell type-phenotype associations across 707 IMPACT regulatory annotations and 111 complex traits and diseases at Ο* 5% FDR, color indicates βlog10 FDR 5% adjusted P value of Ο*. Zooms shows particular cell type categories enriched for polygenic trait associations.
Proportion of heritability in the top 5% of SNPs.a) Common SNP heritability captured by the top 5% of SNPs according to the lead cell type association for each EUR GWAS. Lead association determined by largest Ο* estimate that is significantly positive. b) Similar for each EAS GWAS. Gray bars indicate the standard error of the heritability estimate. Color represents the category of the complex trait or disease.
Ο* comparison of IMPACT annotations versus cell-type-specific histone marks.Comparison of two different functional annotations, IMPACT and cell-type-specific histone marks, to capture polygenic heritability assessed by quantifying Ο* per-SNP heritability value. Circled are five representative traits used throughout the study: asthma, RA, PrCa, MCV, and height.
No entities extracted from this document yet.
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AkiyamaM Characterizing rare and low-frequency height-associated variants in the Japanese population. Nat. Commun 10, 4393 (2019).3156234010.1038/s41467-019-12276-5PMC6764965 | β | β | β |
| AkiyamaM Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat. Genet 49, 1458β1467 (2017).2889206210.1038/ng.3951 | β | β | β |
| AmariutaT IMPACT: genomic annotation of cell-state-specific regulatory elements inferred from the epigenome of bound transcription factors. Am. J. Hum. Genet 104, 879β895 (2019).3100651110.1016/j.ajhg.2019.03.012PMC6506796 | β | β | β |
| AmariutaT, LuoY, KnevelR, OkadaY & RaychaudhuriS Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis. Immunol. Rev 294, 188β204 (2019).3178216510.1111/imr.12827PMC7047592 | β | β | β |
| AndersonHL, BrodskyIE & MangalmurtiNS The evolving erythrocyte: red blood cells as modulators of innate immunity. J. Immunol 201, 1343β1351 (2018).3012706410.4049/jimmunol.1800565PMC6108441 | β | β | β |
| Bulik-SullivanBK LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet 47, 291β295 (2015).2564263010.1038/ng.3211PMC4495769 | β | β | β |
| BunielloA The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005βD1012 (2019).3044543410.1093/nar/gky1120PMC6323933 | β | β | β |
| ButtariB, ProfumoE & RiganoR Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed. Res. Int 2015, 616834 (2015).2572298410.1155/2015/616834PMC4334626 | β | β | β |
| ChatterjeeN Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat. Genet 45, 405e1β405e3 (2013).10.1038/ng.2579PMC372911623455638 | β | β | β |
| ChatterjeeN, ShiJ & GarcΓa-ClosasM Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet 17, 392β406 (2016).2714028310.1038/nrg.2016.27PMC6021129 | β | β | β |
| ChenKM, CoferEM, ZhouJ & TroyanskayaOG Selene: a PyTorch-based deep learning library for sequence data. Nat. Methods 16, 315β318 (2019).3092338110.1038/s41592-019-0360-8PMC7148117 | β | β | β |
| CurtisD Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia. Psychiatr. Genet 28, 85β89 (2018).3016065910.1097/YPG.0000000000000206 | β | β | β |
| DeyKK Evaluating the informativeness of deep learning annotations for human complex diseases. Nat. Commun 11, 4703 (2020).3294364310.1038/s41467-020-18515-4PMC7499261 | β | β | β |
| DrakeLY B cells play key roles in th2-type airway immune responses in mice exposed to natural airborne allergens. PLoS One 10, e0121660 (2015).2580330010.1371/journal.pone.0121660PMC4372217 | β | β | β |
| DuncanL Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun 10, 3328 (2019).3134616310.1038/s41467-019-11112-0PMC6658471 | β | β | β |
| ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57β74 (2012).2295561610.1038/nature11247PMC3439153 | β | β | β |
| FinucaneHK Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet 50, 621β629 (2018).2963238010.1038/s41588-018-0081-4PMC5896795 | β | β | β |
| FinucaneHK Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet 47, 1228β1235 (2015).2641467810.1038/ng.3404PMC4626285 | β | β | β |
| GazalS Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet 49, 1421β1427 (2017).2889206110.1038/ng.3954PMC6133304 | β | β | β |
| GibbsRA A global reference for human genetic variation. Nature 526, 68β74 (2015).2643224510.1038/nature15393PMC4750478 | β | β | β |
| GurdasaniD, BarrosoI, ZegginiE & SandhuMS Genomics of disease risk in globally diverse populations. Nat. Rev. Genet 20, 520β535 (2019).3123587210.1038/s41576-019-0144-0 | β | β | β |
| GusevA Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat. Commun 7, 10979 (2016).2705211110.1038/ncomms10979PMC4829663 | β | β | β |
| HeinzS Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576β589 (2010).2051343210.1016/j.molcel.2010.05.004PMC2898526 | β | β | β |
| HeymsfieldSB, GallagherD, MayerL, BeetschJ & PietrobelliA Scaling of human body composition to stature: new insights into body mass index. Am. J. Clin. Nutr 86, 82β91 (2007).1761676610.1093/ajcn/86.1.82PMC2729090 | β | β | β |
| HirataM Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200,000 patients with 47 common diseases. J. Epidemiol 27, S9βS21 (2017).2819065710.1016/j.je.2016.12.003PMC5363792 | β | β | β |
| HuY Leveraging functional annotations in genetic risk prediction for human complex diseases. PLoS Comput. Biol 13, e1005589 (2017).2859481810.1371/journal.pcbi.1005589PMC5481142 | β | β | β |
| International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748β752 (2009).1957181110.1038/nature08185PMC3912837 | β | β | β |
| IshigakiK Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat. Genet 52, 669β679 (2020).3251412210.1038/s41588-020-0640-3PMC7968075 | β | β | β |
| KanaiM Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet 50, 390β400 (2018).2940301010.1038/s41588-018-0047-6 | β | β | β |
| KawakamiE, NakaokaS, OhtaT & KitanoH Weighted enrichment method for prediction of transcription regulators from transcriptome and global chromatin immunoprecipitation data. Nucleic Acids Res. 44, 5010β5021 (2016).2713178710.1093/nar/gkw355PMC4914117 | β | β | β |
| KelleyDR Sequential regulatory activity prediction across chromosomes with convolutional neural networks. Genome Res. 28, 739β750 (2018).2958836110.1101/gr.227819.117PMC5932613 | β | β | β |
| KheraAV Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet 50, 1219β1224 (2018).3010476210.1038/s41588-018-0183-zPMC6128408 | β | β | β |
| KichaevG & Pasaniuc, B. Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet 97, 260β271 (2015).2618981910.1016/j.ajhg.2015.06.007PMC4573268 | β | β | β |
| KichaevG Leveraging polygenic functional enrichment to improve GWAS power. Am. J. Hum. Genet 104, 65β75 (2019).3059537010.1016/j.ajhg.2018.11.008PMC6323418 | β | β | β |
| KulloIJ Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial). Circulation 133, 1181β1188 (2016).2691563010.1161/CIRCULATIONAHA.115.020109PMC4803581 | β | β | β |
| LamM Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet 51, 1670β1678 (2019).3174083710.1038/s41588-019-0512-xPMC6885121 | β | β | β |
| LeeSH, GoddardME, WrayNR & VisscherPM A better coefficient of determination for genetic profile analysis. Genet. Epidemiol 36, 214β224 (2012).2271493510.1002/gepi.21614 | β | β | β |
| LiuX, LiYI & PritchardJK Trans effects on gene expression can drive omnigenic inheritance. Cell 177, 1022β1034.e6 (2019).3105109810.1016/j.cell.2019.04.014PMC6553491 | β | β | β |
| Lloyd-JonesLR Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun 10, 5086 (2019).3170491010.1038/s41467-019-12653-0PMC6841727 | β | β | β |
| LuiJC & BaronJ Mechanisms limiting body growth in mammals. Endocr. Rev 32, 422β440 (2011).2144134510.1210/er.2011-0001PMC3365796 | β | β | β |
| MaierAB, van HeemstD & WestendorpRGJ Relation between body height and replicative capacity of human fibroblasts in nonagenarians. J. Gerontol. A Biol. Sci. Med. Sci 63, 43β45 (2008).1824575910.1093/gerona/63.1.43 | β | β | β |
| MartinAR Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet 51, 584β591 (2019).3092696610.1038/s41588-019-0379-xPMC6563838 | β | β | β |
| MartinAR Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet 100, 635β649 (2017).2836644210.1016/j.ajhg.2017.03.004PMC5384097 | β | β | β |
| MauranoMT Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190β1195 (2012).2295582810.1126/science.1222794PMC3771521 | β | β | β |
| MurphyRA Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care 37, 3213β3219 (2014).2531520610.2337/dc14-0293PMC4237983 | β | β | β |
| MΓ‘rquez-LunaC Modeling functional enrichment improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. Preprint at bioRxiv 10.1101/375337 (2018).PMC852370934663819 | β | β | β |
| MΓ‘rquez-LunaC, LohP-R, South Asian type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol 41, 811β823 (2017).2911033010.1002/gepi.22083PMC5726434 | β | β | β |
| NagaiA Overview of the BioBank Japan Project: study design and profile. J. Epidemiol 27, S2βS8 (2017).2818946410.1016/j.je.2016.12.005PMC5350590 | β | β | β |
| NatarajanP Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation 135, 2091β2101 (2017).2822340710.1161/CIRCULATIONAHA.116.024436PMC5484076 | β | β | β |
| OkadaY Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376β381 (2014).2439034210.1038/nature12873PMC3944098 | β | β | β |
| PetersonRE Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell 179, 589β603 (2019).3160751310.1016/j.cell.2019.08.051PMC6939869 | β | β | β |
| PurcellS PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 81, 559β575 (2007).1770190110.1086/519795PMC1950838 | β | β | β |
| ReshefYA Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk. Nat. Genet 50, 1483β1493 (2018).3017786210.1038/s41588-018-0196-7PMC6202062 | β | β | β |
| Roadmap EpigenomicsConsortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317β330 (2015).2569356310.1038/nature14248PMC4530010 | β | β | β |
| SchaubMA, BoyleAP, KundajeA, BatzoglouS & SnyderM Linking disease associations with regulatory information in the human genome. Genome Res. 22, 1748β1759 (2012).2295598610.1101/gr.136127.111PMC3431491 | β | β | β |
| SchumacherFR Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet 50, 928β936 (2018).2989201610.1038/s41588-018-0142-8PMC6568012 | β | β | β |
| SharpSA Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42, 200β207 (2019).3065537910.2337/dc18-1785PMC6341291 | β | β | β |
| SirugoG, WilliamsSM & TishkoffSA The missing diversity in human genetic studies. Cell 177, 26β31 (2019).3090154310.1016/j.cell.2019.02.048PMC7380073 | β | β | β |
| StahlEA Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet 44, 483β489 (2012).2244696010.1038/ng.2232PMC6560362 | β | β | β |
| VilhjΓ‘lmssonBJ Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet 97, 576β592 (2015).2643080310.1016/j.ajhg.2015.09.001PMC4596916 | β | β | β |
| YangJ Common SNPs explain a large proportion of the heritability for human height. Nat. Genet 42, 565β569 (2010).2056287510.1038/ng.608PMC3232052 | β | β | β |
| YangJ, ZengJ, GoddardME, WrayNR & VisscherPM Concepts, estimation and interpretation of SNP-based heritability. Nat. Genet 49, 1304β1310 (2017).2885417610.1038/ng.3941 | β | β | β |
| YengoL Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry. Hum. Mol. Genet 27, 3641β3649 (2018).3012484210.1093/hmg/ddy271PMC6488973 | β | β | β |
| ZhouJ & TroyanskayaOG Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931β934 (2015).2630184310.1038/nmeth.3547PMC4768299 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. | 2022 | 35790736 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Ancient DNA reveals pervasive directional selection across West Eurasia. | Akbari A et al. | β | 2026 | β |
| Association between polygenic risk for Major Depression and brain structure in a mega-analysis of 50,975 participants across 11 studies. | Shen X et al. | β | 2026 | β |
| Cross-Ancestry Polygenic Prediction: Comparing Methods and Assessing Transferability Across Traits. | Momin MM et al. | β | 2026 | β |
| Plasma Protein Fluctuation Trajectories Over 15βYears Before Rheumatoid Arthritis Onset. | Sun C et al. | β | 2026 | β |
| Polygenic risk scores: Navigating the future of precision medicine through economic, ethical, and scientific advancements. | Nguyen HHK et al. | β | 2026 | β |
| Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases. | Zhang S et al. | β | 2026 | β |
| Whole-genome sequencing of 3135 individuals representing the genetic diversity of the Japanese population. | Higasa K et al. | β | 2026 | β |
| A highly accurate risk factor-based XGBoost multiethnic model for identifying patients with skin cancer. | D'Antonio M et al. | β | 2025 | β |
| Characterization of cis-regulatory elements and functional variants in colorectal cancer using epigenomics and CRISPRi screenings. | Lu Z et al. | β | 2025 | β |
| DeepAnnotation: A novel interpretable deep learning-based genomic selection model that integrates comprehensive functional annotations. | Ma W et al. | β | 2025 | β |
| Efficient blockLASSO for polygenic scores with applications to all of us and UK Biobank. | Raben TG et al. | β | 2025 | β |
| Enhancing polygenic scores for cardiometabolic traits through tissue- and cell-type-specific functional annotations. | Norland K et al. | β | 2025 | β |
| Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers. | Pouget JG et al. | β | 2025 | β |
| Genetic and phenotypic associations of frailty with cardiovascular indicators and behavioral characteristics. | Chen Y et al. | β | 2025 | β |
| Genetic atlas of plasma metabolome across 40 human common diseases: mapping causal metabolites to disease risk. | Li Y et al. | β | 2025 | β |
| Genetic Control of tRNA-Derived Fragments Contributes to Cancer Risk. | Li B et al. | β | 2025 | β |
| Incorporating multiple functional annotations to improve polygenic risk prediction accuracy. | Shao Z et al. | β | 2025 | β |
| JointPRS: A data-adaptive framework for multi-population genetic risk prediction incorporating genetic correlation. | Xu L et al. | β | 2025 | β |
| Massively parallel variant-to-function mapping determines functional regulatory variants of non-small cell lung cancer. | Chen C et al. | β | 2025 | β |
| Methodological opportunities in genomic data analysis to advance health equity. | Lehmann B et al. | β | 2025 | β |
| Mosaic loss of chromosome Y characterises late-onset rheumatoid arthritis and contrasting associations of polygenic risk score based on age at onset. | Uchiyama S et al. | β | 2025 | β |
| Polygenic scores and their applications in kidney disease. | Khan A et al. | β | 2025 | β |
| Application of Genomic Data in Translational Medicine During the Big Data Era. | Zhang Y et al. | β | 2024 | β |
| Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort. | Shah Y et al. | β | 2024 | β |
| Cross-ancestry genetic architecture and prediction for cholesterol traits. | Momin MM et al. | β | 2024 | β |
| Efficacy of federated learning on genomic data: a study on the UK Biobank and the 1000 Genomes Project. | Kolobkov D et al. | β | 2024 | β |
| Enhancing Equity in Genomics: Incorporating Measures of Structural Racism, Discrimination, and Social Determinants of Health. | Rajagopalan RM et al. | β | 2024 | β |
| Enhancing portability of trans-ancestral polygenic risk scores through tissue-specific functional genomic data integration. | Crone B et al. | β | 2024 | β |
| Evaluating and improving health equity and fairness of polygenic scores. | Zhang T et al. | β | 2024 | β |
| Genetic ancestry in population pharmacogenomics unravels distinct geographical patterns related to drug toxicity. | Karamperis K et al. | β | 2024 | β |
| Genetic and molecular architecture of complex traits. | Lappalainen T et al. | β | 2024 | β |
| Genetic effects of sequence-conserved enhancer-like elements on human complex traits. | Zhu X et al. | β | 2024 | β |
| Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia. | Cameron D et al. | β | 2024 | β |
| Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals. | Akiyama M et al. | β | 2024 | β |
| Genome-wide classification of epigenetic activity reveals regions of enriched heritability in immune-related traits. | Stricker M et al. | β | 2024 | β |
| GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the FcΞ³ receptor region. | Ishikawa Y et al. | β | 2024 | β |
| Improving polygenic risk prediction in admixed populations by explicitly modeling ancestral-differential effects via GAUDI. | Sun Q et al. | β | 2024 | β |
| Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization. | Smith JL et al. | β | 2024 | β |
| Population Heterogeneity and Selection of Coronary Artery Disease Polygenic Scores. | Debernardi C et al. | β | 2024 | β |
| Preimplantation Genetic Testing for Polygenetic Conditions: A Legal, Ethical, and Scientific Challenge. | Ginod P et al. | β | 2024 | β |
| Principles and methods for transferring polygenic risk scores across global populations. | Kachuri L et al. | β | 2024 | β |
| Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations. | Capalbo A et al. | β | 2024 | β |
| The PRIMED Consortium: Reducing disparities in polygenic risk assessment. | Kullo IJ et al. | β | 2024 | β |
| Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register. | Hum RM et al. | β | 2024 | β |
| Advances and Applications of Polygenic Scores for Coronary Artery Disease. | Patel AP et al. | β | 2023 | β |
| Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects. | Ito S et al. | β | 2023 | β |
| A Polygenic Risk Score Enhances Risk Prediction for Adolescents' Antisocial Behavior over the Combined Effect of 22 Extra-familial, Familial, and Individual Risk Factors in the Context of the Family Check-Up. | Wang FL et al. | β | 2023 | β |
| Biobank-scale methods and projections for sparse polygenic prediction from machine learning. | Raben TG et al. | β | 2023 | β |
| Blood cell traits' GWAS loci colocalization with variation in PU.1 genomic occupancy prioritizes causal noncoding regulatory variants. | Jeong R et al. | β | 2023 | β |
| cLD: Rare-variant linkage disequilibrium between genomic regions identifies novel genomic interactions. | Wang D et al. | β | 2023 | β |
| Construction and evaluation of the functional polygenic risk score for gastric cancer in a prospective cohort of the European population. | Gu Y et al. | β | 2023 | β |
| Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005-2022. | Fitipaldi H et al. | β | 2023 | β |
| Exploring the genetic basis of coronary artery disease using functional genomics. | LΓ³pez RodrΓguez M et al. | β | 2023 | β |
| Founder population-specific weights yield improvements in performance of polygenic risk scores for Alzheimer disease in the Midwestern Amish. | Osterman MD et al. | β | 2023 | β |
| From function to translation: Decoding genetic susceptibility to human diseases via artificial intelligence. | Long E et al. | β | 2023 | β |
| Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms. | Zhang M et al. | β | 2023 | β |
| Increasing diversity of functional genetics studies to advance biological discovery and human health. | George SHL et al. | β | 2023 | β |
| JointPRS: A Data-Adaptive Framework for Multi-Population Genetic Risk Prediction Incorporating Genetic Correlation | Xu L et al. | β | 2023 | β |
| Lessons Learned From Parsing Genetic Risk for Schizophrenia Into Biological Pathways. | Pergola G et al. | β | 2023 | β |
| Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis. | Panyard DJ et al. | β | 2023 | β |
| Multi-Omics Studies in Historically Excluded Populations: The Road to Equity. | Yang G et al. | β | 2023 | β |
| New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. | Andreassen OA et al. | β | 2023 | β |
| Overestimated prediction using polygenic prediction derived from summary statistics. | Park DK et al. | β | 2023 | β |
| Phenotype integration improves power and preserves specificity in biobank-based genetic studies of major depressive disorder. | Dahl A et al. | β | 2023 | β |
| Polygenic embryo screening: are there potential maternal and fetal harms? | Ginod P et al. | β | 2023 | β |
| Power of inclusion: Enhancing polygenic prediction with admixed individuals. | Tanigawa Y et al. | β | 2023 | β |
| Quantifying portable genetic effects and improving cross-ancestry genetic prediction with GWAS summary statistics. | Miao J et al. | β | 2023 | β |
| SDPRX: A statistical method for cross-population prediction of complex traits. | Zhou G et al. | β | 2023 | β |
| The complex genetic architecture of Alzheimer's disease: novel insights and future directions. | Andrews SJ et al. | β | 2023 | β |
| The Genetically Informed Neurobiology of Addiction (GINA) model. | Bogdan R et al. | β | 2023 | β |
| Addressing the challenges of polygenic scores in human genetic research. | Novembre J et al. | β | 2022 | β |
| Best practices for multi-ancestry, meta-analytic transcriptome-wide association studies: Lessons from the Global Biobank Meta-analysis Initiative. | Bhattacharya A et al. | β | 2022 | β |
| Beyond GWAS: from simple associations to functional insights. | Ishigaki K | β | 2022 | β |
| Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores. | Wang Y et al. | β | 2022 | β |
| Characterization of Genetic Risk of End-Stage Knee Osteoarthritis Treated with Total Knee Arthroplasty: A Genome-Wide Association Study. | Kulm S et al. | β | 2022 | β |
| Clinical utility of polygenic risk scores for coronary artery disease. | Klarin D et al. | β | 2022 | β |
| Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits. | Lencz T et al. | β | 2022 | β |
| Considering strategies for SNP selection in genetic and polygenic risk scores. | St-Pierre J et al. | β | 2022 | β |
| Construction and Application of Polygenic Risk Scores in Autoimmune Diseases. | Khunsriraksakul C et al. | β | 2022 | β |
| Cross-ancestry genomic research: time to close the gap. | Atkinson EG et al. | β | 2022 | β |
| Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. | Aragam KG et al. | β | 2022 | β |
| Distinct transcriptome architectures underlying lupus establishment and exacerbation. | Nakano M et al. | β | 2022 | β |
| Fine mapping with epigenetic information and 3D structure. | Orozco G | β | 2022 | β |
| Functional studies of lung cancer GWAS beyond association. | Long E et al. | β | 2022 | β |
| Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. | Lai D et al. | β | 2022 | β |
| Genome-wide association study identifies SjΓΆgren's risk loci with functional implications in immune and glandular cells. | Khatri B et al. | β | 2022 | β |
| Genome-wide risk prediction of common diseases across ancestries in one million people. | Mars N et al. | β | 2022 | β |
| Importance of Including Non-European Populations in Large Human Genetic Studies to Enhance Precision Medicine. | Ju D et al. | β | 2022 | β |
| Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores. | Weissbrod O et al. | β | 2022 | β |
| Leveraging the local genetic structure for trans-ancestry association mapping. | Xiao J et al. | β | 2022 | β |
| Longer screen time utilization is associated with the polygenic risk for Attention-deficit/hyperactivity disorder with mediation by brain white matter microstructure. | Yang A et al. | β | 2022 | β |
| Multiancestral polygenic risk score for pediatric asthma. | Namjou B et al. | β | 2022 | β |
| Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. | Ishigaki K et al. | β | 2022 | β |
| Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk. | Schaid DJ et al. | β | 2022 | β |
| Polygenic risk, population structure and ongoing difficulties with race in human genetics. | Kaplan JM et al. | β | 2022 | β |
| Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association. | O'Sullivan JW et al. | β | 2022 | β |
| Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries. | Liang Y et al. | β | 2022 | β |
| Predicted gene expression in ancestrally diverse populations leads to discovery of susceptibility loci for lifestyle and cardiometabolic traits. | Highland HM et al. | β | 2022 | β |
| Prediction of evolutionary constraint by genomic annotations improves functional prioritization of genomic variants in maize. | Ramstein GP et al. | β | 2022 | β |
| Recent advances in understanding the genetic basis of systemic lupus erythematosus. | Ha E et al. | β | 2022 | β |
| Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: Experiences from the NHLBI TOPMed program. | Khan AT et al. | β | 2022 | β |
| Towards a global view of multiple sclerosis genetics. | Jacobs BM et al. | β | 2022 | β |
| Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations. | Dikilitas O et al. | β | 2022 | β |
| A unified framework for cross-population trait prediction by leveraging the genetic correlation of polygenic traits. | Cai M et al. | β | 2021 | β |
| Cell type-specific and cross-population polygenic risk score analyses of <i>MIR137</i> gene pathway in schizophrenia. | Yao Y et al. | β | 2021 | β |
| Ethical concerns relating to genetic risk scores for suicide. | Docherty A et al. | β | 2021 | β |
| From variant to function in human disease genetics. | Lappalainen T et al. | β | 2021 | β |
| GenNet framework: interpretable deep learning for predicting phenotypes from genetic data. | van Hilten A et al. | β | 2021 | β |
| Monogenic and Polygenic Models of Coronary Artery Disease. | Muse ED et al. | β | 2021 | β |
| Multi-omics approach to precision medicine for immune-mediated diseases. | Ota M et al. | β | 2021 | β |
| Of Screening, Stratification, and Scores. | Knoppers BM et al. | β | 2021 | β |
| Predicting Multiple Sclerosis: Challenges and Opportunities. | Hone L et al. | β | 2021 | β |
| Quantitative Human Paleogenetics: What can Ancient DNA Tell us About Complex Trait Evolution? | Irving-Pease EK et al. | β | 2021 | β |
| RΓ‘pidoPGS: a rapid polygenic score calculator for summary GWAS data without a test dataset. | Reales G et al. | β | 2021 | β |
| The Propagation of Racial Disparities in Cardiovascular Genomics Research. | Clarke SL et al. | β | 2021 | β |
| Utility of polygenic embryo screening for disease depends on the selection strategy. | Lencz T et al. | β | 2021 | β |